Article
Breakingviews - Syngenta IPO delay rekindles past China fears
Rating:
0.0
Views:
82
Likes:
1
Library:
1
Syngenta's bumpy relisting path in the People's Republic brings back unpleasant investor memories. The Swiss-turned-Chinese agrichemicals and seeds giant has been waiting since mid-2021 for regulators to clear its mammoth $9 billion initial public offering (IPO) on Shanghai's Nasdaq-like Science and Technology Innovation Board (STAR). The Shanghai Stock Exchange had scheduled this week a hearing, one of the last steps before listing.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value